Quick Facts Flashcards
Pheo w/up:
- Spot plasma or urine metanephrine (sensitive)
- 24-urine metanephrine (specific)
- CT (> MRI)
- MIBG (if suspect multi-focal)
Mucinous cystic neoplasm - dx and tx
- dx: EUS-FNA w/ high CEA (>190), low Amylase
- tx: resect
Tx pelvic fx
- Binder
- Angio OR packing w/ fixation (especially if IR n/a)
- Early external fixation
- refractory bleed after angio → packing + fixation
**MC source is presacral venous plexus
Dx and Localize a gastrinoma
Dx:
1. Off PPI: G > 1000 or >200 w/ secretin stimlation
2. Can’t get off PPI: SS Scintigraphy
Localize:
1. Triphasic CT/MRI
2. SS Scintography (Dotatate PET/CT)
3. Endoscopic US
4. Selective intra arterial Ca
5. OR: Intra-Op US, transduodenal palpation, duodenotomy, palpate HOP
Tx pseudocyst/WON
Dx: US or CT
- if can’t r/o cystic neoplasm on imaging must get EUS-FNA
Tx: drain if persistent sxs. Wait 4-6 weeks for the wall to mature
- near stomach/duo, > 6cm: endoscopic cystogastrostomy/duodenostomy
- open or lap cysto-enterostomy (usually jejunostomy if not abutting duo or stomach)
Tx of pancreatitis masses
1. WON sterile
2. WON infected
3. Pseudocyst
4. Infected pseudocyst
- WON sterile: conservatively
- WON infected: step-up approach
- Pseudocyst: tx if sxs (infxn, obstruction, pain)
- 4-6w → internal drain → cyst-enterostomy - Infected pseudocyst: drainage (internal, external, endoscopic). Endoscopic preferred.
Indications to tx ICA stenosis and sxs
- Asx: > 60%
- Sxs: > 50% (>125 cm/s)
- Sxs: contralateral motor/sensory sxs, ipsi vision sxs
Bethesda criteria for thyroid
**1 cm is cutoff to get an FNA
- Non-diagnostic → repeat FNA
- Benign → follow-up
- Undetermined significance → repeat FNA or lobectomy
- Follicular neoplasm → lobectomy
- Suspicious for malignancy → lobectomy vs. thyroidectomy
- Malignant → thyroidectomy
Achalasia - Px, Dx, Path and Tx
Px: dysphagia (to solid and liquid) is MC sx
Dx:
- no peristalsis
- high LES pressure > 15 (vs. scleroderma, low)
- incomplete relaxation
Path: injured ganglion cells
Tx: only motility disorder w/ upfront surgery
- myotomy (6 eso, 2 stomch) is 1st line (avoid Nissen).
- botox or dilation if high risk.
Tx Medullary thyroid cancer
- TOTAL thyroidectomy
- > 1 cm or bilobar: bilateral central/level 6 dissection
- Lateral neck dissection on that side if central+
- Start T4 postop. Monitor w/ calcitonin AND CEA
- RAI is c/i! (C cell origin)
Radial scar- Dx and Tx
- Dx: aka comlpex sclerosing lesion
- Mammo: spiculated mass with central sclerosis (lucency) and surrounding distortion
- Histo: fibroelastic core w/ entrapped ducts
Gross: white center (central scar) - Tx: core bx ➡ excisional bx (to r/o ca)
Tx mucinous neoplasm of the appendix
- Confined to appendix: appe only (no LADN’y)
- must have negative margin
- scope in 6w to r/o sync lesions - Involving base, ruptured, or +margin: R hemi +/- LADN
- Peritoneal dissemination: perc bx
- if appendicitis: remove ruptured segment + directed peritoneal bx
- no appendicitis: postpone appe until cytoreductive surgery
- no hipec/cancer operation until staged
**need post-op scope to r/o synchronous lesions
When to excise burns
- < 72 hours but not until after appropriate fluid resuscitation
- Used for deep 2nd-, 3rd-, and some 4th-degree burns
- Viability is based on punctate bleeding (#1), color, and texture after removal (use dermatome)
Liver lesions on arterial phase:
HCC
Mets
Adenoma
Hemangioma
FNH
- HCC: rapid enhancement. rapid w/out. “hot” on nuclear imaging
- Mets: Hypoattenuation
- Adenoma: rapid enhancement. rapid w/out. “cold” on nuclear imaging. gado/eovist not retained
- Hemangioma: peripheral nodular enhancement. delay: centripetal fill-in (no early washout!)
- FNH: Centrifugal enhancing. w/out except for scar enhancement. take up sulfer colloid and gado/eovist
Elective surgery after stent
- ASA lifelong
- Plavix
- BMS: 1 month
- DES: 6 months (ideally). Can be 1 month if needed for urgent surgery (cancer)
Teg interpretation:
R time
K time
a angle
MA
LY 30
R time- FFP
K time- cryo
a angle- cryo
MA- PLTs
LY 30- TXA
Rule of 6’s:
R > 6 minutes
alpha angle > 60 degrees
MA < 60 mm
LY30 > 6%
Tx and Survival Benefit of ARDS
- TV at 4-6 ml/kg
- Permissive hypercapnia
- Proven benefit: prone, lung protection, paralyze
-P/F < 100 = severe
Glucagonoma - loc, px, dx, tx
Loc: distal (a cells)
Px: dermatitis, DRH, DM, nec mig erythema
- most malignant
- no stones (vs. SS’oma)
Dx: gluc > 1000
Tx: distal panc + splenectomy + LADN’y + CC’y
z11 trial implications
- If less than 3 nodes positive on SLN and T1 or T2 disease, BCT is OK
- if >70, t1, ER+ and SNLBx neg ➡ can consider no XRT after lumpectomy
Hard signs of vascular injury
shock
expanding hematoma
pulsatile bleed
thrill/bruit
absent pulse
ischemia
If negative ➡ ABI…if positive ➡ CTA (to localize)
Polyps that require surgery instead of endoscopic resection
- Submucosal invasion > 1mm
- Poorly differentiated
- <1 mm margin
- LV invasion
- Tumor budding
- Taken piecemeal
T staging indications for neoadjuvant
- eso
- stomach
- colon
- rectal
- lung
- eso: T2 (MP)
- stomach: t2 (MP)
- colon: t4b (adjacent organs)
- rectal: t3 (through MP)
- lung: n2 nodes
Screening in IBD patients
- Start 8 years after sx onset
- 2-4 random bx every 10 cm throughout the colon + suspicious areas
Repeat schedule:
- normal: q1-3 years
- PSC, stricture, or dysplasia w/out colectomy: q1 year
Any dysplasia usually gets a colectomy
- if resectable can consider endoscopic resection with close surveillance
NEC - px and tx
Px: bloody stools after 1st feed
- prematurity is biggest RF
tx:
- resuscitation, ngt, abx (no surgery) x 7-10 day (50% success)
-surgery (50%): resect all non-viable segments. create stoma.
W/up of thyroid nodule found on exam or incidental imaging
- U/S and TSH:
a. Nodule + Low TSH ➡ RAI uptake scan
- hot/functioning: toxic adenoma (no cancer) ➡ thionamide, b-block + lobectomy
- cold: FNA
b. Nodule + Normal/High TSH ➡ FNA
Tx male breast ca
Tx: simple mastectomy w/ SLNBx
- BCT usually can’t be done b/c not enough tissue
- if ER+: tamoxifen (Her2+ is rare). consider orchiectomy if metastatic.
- More likely ER/PR+ than females!
- Prognosis similar to W but delay in px
- a/w BRCA 2/Chromosome 13. Should BRCA test if family hx
General principles - repair of Bile Duct Injury
- Intro-op:
- convert to open, intra-op cholangio, repair OR
- widely drain and send to specialty center - Post-op:
- Perc cholangiography to define the anatomy
- Control spillage: external drain +/- stent +/- PTC
- Repair in 6-8 weeks
Eso dysplasia tx
- LGD: ablation OR scope q6-12m
- OK for fundoplication - HGD: ablation + Q3m scope
- fundoplication c/i - T1a: ablation
- t1b (or low risk T2): upfront esophagectomy
*Fundoplication does not decrease cancer risk
Tx hemobilia after trauma
- EGD → CTA (if stable)
- angio embolization (no surgery)
- catheterize the celiac artery first ➡ R/L hepatic ➡ SMA
Indications for chemotherapy for rectal cancer
- Neoadjuvant:
Stage 2 and above - Adjuvant chemo as well for Stage 3+ (nodes)
**XRT either pre or post-op (not both)
**Typical course: chemo-XRT ➡ surgery ➡ chemo
Periop anticoagulation - risks and tx
Risks:
- High risk pt: afib, MHV, recent TE event (3m)
- High risk surgery: nsurg, optho, cards
Tx:
- bridge for high-risk patients
- stop warfarin 5 days before surgery if not bridging, resume on day of surgery
- Hold Noac 2 days before surgery and resume 1 day after
- stop Plavix 5 days before
- resume AC within 24h for low risk surgery. 48-72h for high risk surgery.
Margin for invasives cancer vs. dcis
- Invasive cancer- no tumor on ink
- DCIS- 2 mm
**if both in specimen, margin is no tumor on ink
Neuroblastoma dx and tx
dx:
- CT: displacement of renal parenchyma (vs. Wilm’s)
- Can also use MIBG and VMA levels (like pheo)
- Usually adrenal. Can also be neck, chest, spine
- neck can px w/ horner syndrome
- tissue bx to get n-myc status
tx:
1. S1-2 (low risk) → surg alone
2. S3+ or n-myc+ (high risk) → chemo/XRT then XRT
- need bx: chemo regimen determined by n-myc amplification
TEF - MC types
dx and tx
- Type C - MC, 85%
- Proximal esophageal atresia (blind pouch) and distal TE fistula
- dx: AXR ➡ distended, gas-filled stomach, coiling tube
- no UGI needed! - Type A: second most common, 5%
- Esophageal atresia and no fistula
- dx: XR: gasless abdomen, coiling tube
- no UGI needed!
Tx:
1. Resuscitate w/ repogle tube
2. Echo: VACTERL cardiac w/up
3. G-tube placement to decompress and feed
4. Delayed RIGHT extra-pleural thoracotomy
5. Distal ligation of TEF (if gas in abdomen, type C)
**long term r/o dysphagia and GERD in almost ALL patients
Birads score
0- redo imaging
1- negative, NTD
2- benign, NTD
3- benign, repeat q6m
4- suspicious, bx
5- highly suspicious, bx
6- confirmed, excise
**discordance: perform repeat bx w/ surgical excision or core bx (if there was a correctable error)
PFTs for lung resection
- Preop FEV1 and DLCO predicted > 80% ➡ no further testing
- >.8L wedge, >1.5L lobe, >2L pneumo
- < 80% ➡ lung scan for PPO FEV1, DLCO - PPO FEV1, DLCO > 60% ➡ no further testing
- < 60% ➡ exercise test - VO2 > 10 ml/min/kg ➡ OK for surgery
- < 10 ➡ high risk for surgery
Gastrinoma - loc, px, dx, tx
Loc: gastrinoma triangle (CBD, panc neck, 3D)
Px: refractory PUD
- Mostly malignant
Dx: G > 1000 (off PPI) or >200 w/ secretin (off PPI)
- SS Scintigraphy (dotatate scan) if can’t get off PPI
- MRI for regional disease
Tx: Screen for MEN1
- <2 cm: enucleate w/ LADN’y
- > 2cm: resect w/ LADN’y
W/up of pancreatic cystic neoplasms:
Pseudocyst
Serous cystadenoma
MCN
IPMN
- MRI
- EUS w/ FNA (If unclear):
-Pseudocyst: high Am, low CEA
-Serous cystadenoma: low Am, low CEA
-MCN: low Am, high CEA (>200)
-IPMN: high Am, high CEA (>200)
***High CEA > 190
Indication for APR
- Rigid proctoscopy: w/ in 2cm of anal verge (levators)
- PE: baseline sphincter dysfxn
- Recurrent SqCC (s/p Nigro)
Somatostatinoma - loc, px, dx, tx
Loc: head
Px: DM, GALLSTONES (> glucagonoma), steatorrhea, block exo/endo pancreas
- most malignant
Dx: sx’s + high fast SS
Tx: resect + LADN’y + CC’y
EVAR specs:
- Proximal landing
- Common iliac (distal landing)
- Neck angulation
- External Iliac
Proximal landing: > 1.5 cm
- diameter < 3cm
Common iliac (distal landing): > 1 cm
- diameter > 8 mm
Neck angulation < 60 degrees
External Iliac diameter> 7mm
**smoking is stronger RF for AAA
**extensive calc is a c/i
Tx of anal fissure
- Sitz bath, fiber
- topical nifedipine/nitroglycerin
- nitro causes headache - Surgery (or botox)
- Good sphincter tone: LATERAL, INTERNAL sphincterotomy
- Poor tone: botox
**If 2/2 crohn’s dz: optimize medical management
Tx of liver lesions:
1. Hemangioma
2. FNH
3. Adenoma
- Hemangioma: only if sxatic or KM syndrome
- enucleate (or resect); angioembo if active bleed - FNH: NTD
- Adenoma: resect if < 4cm w/out OCP response or > 4 cm, male, or growing
Dx and Tx congential DPGM hernia
-Dx: prenatal dx on US ➡ must confirm with MRI
-Tx:
1. intubate (in delivery room)
- goal O2 > 60, CO2 < 60
2. NGT +/- ECM
3. delay OR when stable
Supraceliac aortic control
- HDUS: Enter lesser sac through gastrohepatic ligament, divide posterior crus of diaphram
- Stable: left medial visceral rotation is preferred
Dx and Tx Phyllodes
Bx: stromal overgrowth, atypia, high MI, “leaf-like”
- aggressive fibroepithelial lesion
- non aggressive is fibroadenoma
Tx: WLE w/ 1 cm margin + XRT (if > 5cm)
- can spread hematogenous to lung (more than ax nodes)
Indications for total thyroidectomy (pap and follicular)
Indications for total thyroidectomy:
- Tumor > 4cm
- Tumor 1-4cm and patient preference
- Distant mets or extra-thyroid disease
- Nodal disease
- Poorly differentiated
- Prior radiation
*micro-mets do not count as distant disease
**if thyroid lobectomy only: tx with thyroid hormone to suppress TSH, get serial U/S to monitor
Soft tissue sarcoma - dx and tx
dx:
- < 3cm: excisional bx
- > 3 cm: core needle (preferred) or incisional
tx:
- resect w/ 2 cm marg
- neoadj: rhabdomyo, Ewing, high grade, > 10 cm
- adj XRT: > 5cm, high grade, recurrence, close marg
- adj chemo: never
Step up approach
Infected pancreatic necrosis (WBC + gas on CT)
- CT with gas
- Carbapenem
- FNA + Perc drain OR endo drain (if stomach is close to pancreas)
- Upsize drain
- MIS retrop necrosectomy (VARD)
- Open necrosectomy
Types and Tx SVT
types: af, aflutter, paroxysmal SVT, WPW
- vagal → adenosine
- may unmask afib/flutter - HDS: BB, CCB ➡ sync cardioversion
- HDUS ➡ sync cardioversion
Melanoma w/up and tx
- Punch bx or excisional bx (if < 2cm, non-sensitive area)
- MIS- 5mm margin
- <1mm- 1cm
- 1-2mm- 1-2cm
- >2mm- 2cm - Clinical positive nodes (stage 3) require FNA for confirmation
- negative: SLNBx
- positive: completion LN dissection - SLNBx: > 1mm (T2) or if .75-1 mm w/ ulceration or mitotic rate > 1 (T1b)
- If SLNBx+ (stage 3): q4m US surveillance OR completion LN dissection
- LN dissection: superficial 1st. Deep if cloquets+, clinically+ positive, >3+ on SLNBx, or CT+ for deep nodes
**MOHS can be used for in-situ disease. Need 5 mm margin.
Steps of rapid sequence intubation
c-spine stabilize → preO2 → fentanyl → etomidate → succinylcholine
Px, Dx and Tx malrotation
Px: bilious emesis
Dx: UGI duodenum does not cross midline
- should be done in all infants with bilious emesis
Tx: urgent OR (risk of malro)
1. resect Ladd’s bands
2. widen the mesentery (resect central bands)
3. counterclockwise rotation
4. place cecum in LLQ (cecopexy), duodenum in RUQ
5. appendectomy
MEN syndromes
1- pancreatic (gastrin), pituitary (prolactin), parathyroid (PTH); menin; AD
2a- Parathyroid (PTC),MTC, Pheo (catecholamines); ret; AD
2b- Pheo, MTC, marfanoid/neuroma; ret; AD
lower extremity bypass graft failure depends on temporal relation to the surgery.
- <30d: technical error
- 1m-2y: intimal hyperplasia, (at the distal anastomosis)
- > 2y: progressive atherosclerotic disease
Dx and Tx Parathyroid ca
Dx: palpable neck mass + Ca > 14 is presumptive dx. Otherwise, dx intra-op based on gross features.
- FNA is not recommended
- Treat based on intra-operative gross invasion. Frozen section is not helpful.
Tx:
1. Control hypercalcemia: usually > 14
- IV fluids 1st! Then bisphosphonates
- cinacalcet (sensipar - ca mimetic)
- Parathyroidectomy w/ hemithyroidectomy (+/- L6/central neck dissection +/- XRT)
- no chemo
- usually don’t perform any node dissection unless palpable nodes
Mechanism and Tx of thyroid dz:
1. Graves
2. TMN
3. Hashimoto’s
4. DeQuervains/Subacute
5. Reidels
- Graves: IgG stimulates TSHr ➡ hyperT
- BB, PTU, RAI ➡ thyroidectomy - TMN: chronic TSH stimulation ➡ hyperT
- BB, PTU, RAI ➡ total/subtotal thyroidectomy - Hashimoto’s: antiTPO/TG Ab ➡ hypoT
- thyroxine ➡ partial thyroidectomy - DeQuervains/Subacute: viral URI
- path: giant cells, leukocytes
- NSAIDS/ASA ➡ steroids - Reidels: autoimmune inflammation
- steroid, thyroxine ➡ surgery for compression
Sonograph FNA recs
- cystic: no bx
-isoech/hyperech: FNA if > 2cm
-hypoech (high sus): FNA if > 1cm
Triple therapy
PP1 + 2 antibiotics abxs: amoxicillin, metronidazole, tetracycline, clarithromycin for 2 weeks
Gail model
- age
- age 1st period (earlier is worse)
- age 1st birth (earlier is better)
- 1d relative
- previous bx
- race
types of endoleak and tx
- proximal/distal seal: immediate balloon expansion of distal/proximal attachments + stent
- 1a: proximal leak
- 1b: distal leak - back bleeding: observe. coil embolization if enlarging
- graft defect (tear or junctional leak): immediate additional graft coverage
- porosity- reverse anticoagulation
Carcinoid vs. GIST vs. Desmoid- cells and tx
- Carcinoid- Kulchinsky cells (enterochromaffin-like)
tx- < 2cm ➡ appendectomy; > 2cm ➡ R hemi/oncologic resection; chemo if unresectable - GIST- cajal cells
tx- resection (MC stomach), imantinib - Desmoid- spindle cells
tx- resect if extra-abdominal. NSAID/estrogen if intra
Hyperaldosterone w/up
Px: resistant HTN and hypokalemia
- AM plasma aldo/renin
- A/R < 20: 2nd hyperaldo
- A/R > 20: primary hyperaldo ➡ - Confirmatory test: salt load suppression test
- give salt load ➡ 24h urine aldo remains elevated - Discern laterality: CT scan! (>MRI)
A. Unilateral: lap adrenal (consider adrenal vein sampling 1st if > 35 to r/o BAH)
B. Bilateral or negative ➡ adrenal vein sampling
- Lateralization: lap adrenal
- No lateralization: idiopathic hyperplasia ➡ tx medically
**tx HTN with spironolactone
Dx and Tx of SBP
dx: ↑ascitic PMN ANC > 250 (Se) and
- don’t require culture (Sp)
- e. coli is MC (usually single organism)
tx:
1. paracentesis for cx
2. abxs:
- <48h/community acquired: 3GC
- >48h/hospital acquired: carbapenem + MRSA coverge (dapto)
3. Albumin (survival benefit)
Tx acute variceal HMHG
- Resuscitate, ensure airway
- Octreotide + antibiotics
- Endoscopic intervention (ligation/sclerotherapy)
- Blakemore
- TIPS (temporized with Blakemore)
Tx SVC syndrome tx
- Elevate HOB
- Chest CT with IV contrast (can skip CXR)
- Consider bronch
- Assess sxs
A. Life-threatening sxs: secure airway ➡ consider AC (if thrombus) ➡ venogram ➡ endovascular stenting
B. Mild sxs ➡ tissue bx ➡ decide on XRT/chemo
- no chemo/XRT unless its 2/2 cancer
Tx appendicitis
- Uncomplicated: lap appe
- Septic/Unstable: immediate lap appe
- Stable w/ abscess
- < 3cm: lap appe
- > 3cm: IR drain ➡ interval appe, offer scope - Crohn’s ileitis
- intra-op with normal appendix AND cecum ➡ appe to r/o dx uncertainty
Tx MEN2A/B
- urine metanephrine to r/o pheo 1st
- tx pheo 1st w/ adrenalectomy
- Address thyroid
- 2A: total thyroid + bilateral central neck by 5y
- 2B: total thyroid + bilateral central neck by 1y
Tx MEN1
- HyperPTH 1st w/ 4-gland resection (hyperplasia not adenoma) + thymectomy (remove ectopics)
- Asses other lesions
Prog and Tx anaplastic thyroid ca
Prognosis:
- aggressive, undiff
- mort ~ 100%; no tx
Tx: XRT improves short-term survival +/- surg
- BRAF inhibitor for chemo
Criteria for transanal excision of adenocarcinoma
- T0 or T1 (submucosa)
- < 3 cm
- < 30% circumference
- Palpable on DRE (<8cm from anal verge)
- No high-risk features (poorly diff, LV invasion)
**local recurrence rate is higher
HNPCC screening and treatment
CRC: scope q1-2y starting at 20-25
- Surgery if:CRC or endoscopically unresectable lesions
- TAC with IRA w/ q1y rectum surveillance
- endometrial/ovarian cancer screening
Dx and Tx choledochal cyst
Dx: U/S or HIDA
Tx:
1. fusiform dilation: REY-HJ
2. diverticulum: simple excision
3. choledococele: transduo excision vs. sphincteroplasty
4a. intra + extra dilation: hepatic resection + recon
4b. extra only: excision + recon
5. intra only: transplant
Px, Dx, and Tx:
Duo atresia
TEF
Pyloric stenosis
Intussusception
Malro
Duo atresia: newborn; bilious emesis directly after birth
- a/w down syndrome
-dx: AXR- double bubble with no gas distally. don’t need UGI
-tx: duodenoduodenostomy
TEF: newborn, spit ups. can’t place NG. resp sxs
- dx: AXR- gasless (A), gas (C)
- tx: right extra-pleural thoracotomy
Pyloric stenosis: 1-3 months; NB projectile vomiting
-dx: U/S- 4mm thick, 14 mm long. String sign on UGI
-tx: pyloromyotomy (1-2 from duo to antrum)
Intussusception: 3m-3y; currant jelly stool
- dx: U/S w/ bull’s eye
- tx: air contrast enema
Malro: 1y-5y; sudden onset bilious emesis
- dx; UGI- no duo sweep (any child w/ bilious emesis)
- tx: ladd’s procedure
Tx of GB cancer
1a: LC only
- lap chole only
- excise to negative CD margin
1b: muscle involved
- OPEN chole + seg 4b and 5 + portal LADN
- CD margin positive: REY-HJ
**high suspicion for GB Ca should also get an open chole (polyp > 2cm)
Tx of CBD stone intra-operatively
- Flush ➡ glucagon x 2
- Lap exploration
A. Transcystic: stone < 1 cm, <8 stones, no CHD stones
B. Lap CBD: stone > 1cm, > 8 stones, CHD or junction stones - Open exploration: if lap exploration failed
- CBD < 2 cm: trans-duo sphincteroplasty
- multiple stones, CBD > 2 cm: biliary-enteric drainage.
- Leave T-tube
**thin CD can be dilated
W/up Hurthle Cell Cancer
- FNA- hurthle cells (can be seen in other conditions)
- Lobectomy 1st for diagnosis
- If malig: total thyroidectomy +/- L6 nodes
- If palpable nodes: MRND
No RAI
Hernia repairs:
Bassini
McVay
Lichtenstein
Shouldice
Bassini: conjoint tendon to inguinal ligament (from pubic tubercle medially to internal ring laterally)
- may need relaxing incision in anterior rectus sheath
McVay: open the floor to ➡ conjoint tendon to cooper’s/pectineal ligament.
- transitional stitch from conjoint, cooper’s, and femoral sheath at medial aspect of femoral vein
- re-approximate the rest of the inguinal floor by suturing the conjoint tendon to the inguinal ligament
- may need relaxing incision
Lichtenstein: mesh to inguinal ligament and conjoint tenown
Shouldice: divide the floor ➡ 4-layer tissue closure
Tx for cholangiocarcinoma
Tx:
1. Resectable if:
- contralateral hemi-liver with intact HA, PV, and biliary drainage with no tumor
- no distant mets or organ invasion
- Consider location
- Upper ⅓ (Klatskin): lobectomy and stenting of contra lobe
- Middle ⅓: hepaticojejunostomy
- Lower ⅓: Whipple - Chemo + transplant if unresectable
IPMN - dx and tx
dx: MRI 1st! then EUS/FNA; high CEA, high amylase
tx:
1. Branched
- resect if >3 cm, sxs, or signs of malig (nodule)
- Otherwise surveillance
2. Main duct
- resect if > 1 cm or sxs (60% chance of Ca)
- 5-9 mm EUS/FNA. Resect if SOMalig
- < 5mm, surveillance MRIs
Path, Dx and Tx of Zenkers
Path: outpouching SUPERIOR to cricopharyngeous
Dx: UGI (don’t do EGD) ➡ manometry (r/o dysmotility)
Tx: open or scope approach:
<2cm : myotomy alone
>2cm: multiple options
- consider endoscopic stapling +/- myotomy
- 2-5 cm: myotomy with suspension or inversion
- larger: diverticulectomy with myotomy
VIPoma - loc, px, dx, tx
Loc: distal
Px: watery DRH- hypoK, met acid. achlorhydria, inhibits gastrin
- DRH ➡ bicarb sexn ➡ met acid
- most malignant
Dx: high VIP
Tx: distal panc + splenectomy + LADN’y + CC’y
Gastric CA tx - chemo, margins, nodes
- neo-adj chemo for T2+ or N
- proximal- total gastrectomy
- distal- partial
- 5 cm margin; 15 nodes
- Can consider endoscopic mucosal resection: if < 2cm, well-differentiated, mucoa only, no LV invasion
Milan criteria
indications for trx w/ HCC
- Single tumor < 5cm
- No more than 3 tumors each < 3 cm
**Hepatectomy if compensated cirrhosis (no portal HTN), low MELD, and solitary mass < 3 cm is still preferred
**5-year transplant pt survival is 65-90%
indications for trx of cholangioca
- cant be intrahepatic
- must be unresectable, perihilar, < 3cm
- no distant mets
Insulinoma - loc, px, dx, tx
Loc: throughout (B cells)
Px: whipple’s triad. Most benign.
Dx: I/G > .4 and high C-pep
- dx w/ fasting test 1st!
- endoscopic U/S most sensitive for detection
Tx: < 2cm encucleate, >2cm resect.
- High carb diet 1st
- Diazoxide if can’t tolerate surgery
- LADN’y if suspect malignancy
Specific to Crohn’s and UC
- Crohn’s:
- Creeping fat
- Skip lesions
- Transmural
- Cobblestoning
- Granulomas
- Fistulas - UC:
- Crypt abscess
- Pseudopolyps
Gastric ulcers: elective classification and management
Dx- EGD and Bx (Bx needed to r/o ca!)
Tx-only tx if refractory to max medical management after 12 weeks.
- lesser curve/antrum; normal acid ➡ distal gastrectomy w/ bil 2
- gastric + duo; high acid ➡ antrectomy + vagotomy
- pre pyloric: high acid ➡ antrectomy + vagotomy
- GE junction: normal acid ➡ sub-total gastrectomy + REY
Emergent vs. Elective UC Tx
Emergent:
1. Steroids +/- abxs
2. Infliximab, Cyclosporine
3. No response, megacolon (> 6 cm), HDUS, or perf ➡ TAC with end-ileostomy
- When stabilized can perform proctectomy and IPAA
- Don’t do proctectomy in emergent situations
Elective:
- Indications: dysplasia, cancer, refractory disease
- PC w/ IPAA
** Surgery reduces: erythema nodosum, arthritis
– no effect on PSC or ank spondy
Zone injuries and management
- penetrating:
- zone 1-3 ➡ explore - blunt:
- zone1 ➡ explore
- zone 2-3 ➡ do not explore
FAP - Dx and Tx
Dx: > 100 adenoma or < 100 w/ fam hx
- AD; APC mutation
- CA by 40
- desmoid tumors (slow growing abdominal wall mass)
Tx:
- sigmoidoscopy q1y at 10 (don’t need colonoscopy)
- EGD @ 20 or when polyps start- SB polyposis
- TAC w/ IRA or PC w/ IPAA depending on rectal involvement at about 20 (or once florid polyposis is seen)
- q1y EGD post op for duodenal cancer (MC COD after colectomy)
- q1y c’scope if TAC
- polyposis/high grade dysplasia @ stump → proctectomy +/- pouch
- desmoid: resect. Anti-E if intra-abdominal
BRCA risks and tx
female breast, ovarian, male breast
I (ch17)- 60, 40, 1
II (ch13)- 60, 10, 10
Tx:
-pre-meno: offer bilateral mastectomy OR q1 MRI starting @ 25
- @ 30 annual MRI w/ mammo
-post meno: bilateral mastectomy + SOO + HRT until 50 (no TAH)
When to operate on adrenal mass
- all functioning tumors
- all > 6 cm ➡ open resection
- if < 6cm with suspicious features - >10HU, <50% @ 10m w/out ➡ open resection
**DO NOT biopsy first
Adjuvent chemo for breast ca
- Adjuvent chemo: tumor > 1cm, nodal dz, triple neg
- echo before for cardiotox - Tamoxifen/Anastrazole: 5y for HR+ tumors
- Tamox for men - Trastuzumab- 1y for Her2/neu+ tumors
- echo before for cardiotox - Olaparib- 1 year for triple negative/BRCA+ tumors
- PARP inhibitor
**Oncotype recurrence score > 26 requires adjuvant chemotherapy
FNH - path, dx and tx
path- CENTRAL STELLATE SCAR!
dx- bright on arterial phase homogenous
tx- resect if sxatic. no malignant potential.